1. Home
  2. FTRE vs SWBI Comparison

FTRE vs SWBI Comparison

Compare FTRE & SWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • SWBI
  • Stock Information
  • Founded
  • FTRE 1996
  • SWBI 1852
  • Country
  • FTRE United States
  • SWBI United States
  • Employees
  • FTRE N/A
  • SWBI N/A
  • Industry
  • FTRE Medical Specialities
  • SWBI Ordnance And Accessories
  • Sector
  • FTRE Health Care
  • SWBI Industrials
  • Exchange
  • FTRE Nasdaq
  • SWBI Nasdaq
  • Market Cap
  • FTRE 483.5M
  • SWBI 397.3M
  • IPO Year
  • FTRE N/A
  • SWBI N/A
  • Fundamental
  • Price
  • FTRE $5.36
  • SWBI $9.52
  • Analyst Decision
  • FTRE Hold
  • SWBI Buy
  • Analyst Count
  • FTRE 11
  • SWBI 2
  • Target Price
  • FTRE $18.00
  • SWBI $12.75
  • AVG Volume (30 Days)
  • FTRE 2.7M
  • SWBI 480.3K
  • Earning Date
  • FTRE 05-12-2025
  • SWBI 03-06-2025
  • Dividend Yield
  • FTRE N/A
  • SWBI 5.54%
  • EPS Growth
  • FTRE N/A
  • SWBI 16.02
  • EPS
  • FTRE N/A
  • SWBI 0.66
  • Revenue
  • FTRE $2,696,400,000.00
  • SWBI $493,046,000.00
  • Revenue This Year
  • FTRE N/A
  • SWBI N/A
  • Revenue Next Year
  • FTRE $3.38
  • SWBI $3.86
  • P/E Ratio
  • FTRE N/A
  • SWBI $14.22
  • Revenue Growth
  • FTRE N/A
  • SWBI N/A
  • 52 Week Low
  • FTRE $4.77
  • SWBI $8.38
  • 52 Week High
  • FTRE $38.04
  • SWBI $17.33
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 37.73
  • SWBI 56.11
  • Support Level
  • FTRE $4.82
  • SWBI $8.38
  • Resistance Level
  • FTRE $5.31
  • SWBI $9.46
  • Average True Range (ATR)
  • FTRE 0.61
  • SWBI 0.40
  • MACD
  • FTRE 0.20
  • SWBI 0.12
  • Stochastic Oscillator
  • FTRE 42.94
  • SWBI 94.08

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

Share on Social Networks: